david j. gorberg & associates, p.c.

32 parking plaza suite 700
ardmore, pennsylvania 19003

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 13, 2013

NYS DOS ID#
4402675

County
ERIE

Jurisdiction
PENNSYLVANIA

Registered Agent
NONE

NYS Entity Type
FOREIGN PROFESSIONAL CORPORATION

Name History
2013 - DAVID J. GORBERG & ASSOCIATES, P.C.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Break Out: Ultima III and the familial origins of Origin Systems
    By David L. Craddock - Saturday Sep 16, 2017

    The following excerpt comes from Break Out: How the Apple II Launched the PC Gaming Revolution by David L. Craddock, available in hardcover from Schiffer Publishing. The book chronicles the making of over a dozen groundbreaking PC games, featuring interviews with their developers and details how they went on to influence the games of today. In […]

    Source: VentureBeat
  • Trump Associate Boasted That Moscow Business Deal ‘Will Get Donald Elected’
    By MATT APUZZO and MAGGIE HABERMAN - Monday Aug 28, 2017

    Emails show that Felix Sater promised to get Vladimir Putin’s support for a Trump Tower in Moscow. “Our boy can become president,” he wrote.

    Source: NYT > Home Page
  • Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand
    By Frank Vinluan - Friday Aug 25, 2017

    In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience. The totality of the solar eclipse lasted less than 3 minutes. If you missed it, you’ll have to wait until 2024 for the next one. […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • David Geffen Criticizes ‘Shameful’ Lack of Support for Concert Hall
    By ROBIN POGREBIN and MICHAEL COOPER - Wednesday Oct 4, 2017

    Mr. Geffen lamented the downsizing of the $500 million David Geffen Hall project at Lincoln Center. “New York should have the best of everything,” he said.

    Source: NYT > Home Page
  • Greg David on NY: Trump's Russia problem reminds me of Watergate
    Monday Jun 12, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business